Amyloidosis: open trials in Spain

23 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

NCT06128629
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Trial Treatment · Phase 3 · Intellia Therapeutics
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitari Vall d'Hebron, Barcelona · Bellvitge University Hospital, L'hospitalet De Llobregat · Hospital Universitario Puerta de Hierro de Majadahonda, Madrid · Hospital Universitario Virgen de la Victoria, Málaga · Hospital Son Llatzer, Palma · Hospital Universitario de Navarra, Pamplona · Hospital Universitario De Salamanca, Salamanca
Registry updated 2026-11-04
NCT06978660
Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis
Research · Idoven 1903 S.L.
Hospital Universitario Juan Ramon Jimenez, Huelva · Hospital Universitario Son Llatzer, Palma de Mallorca · Hospital Universitario Donostia, San Sebastián
Registry updated 2026-11-04
NCT05652335
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Hospital Universitari Germans Trias i Pujol, Badalona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitario Fundación Jiménez Díaz, Madrid · Clínica Universidad de navarra, Pamplona · Hospital Universitario De Salamanca, Salamanca
Registry updated 2026-11-03
NCT07224672
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
Trial Treatment · Phase 2 · GlaxoSmithKline
Hospital Clinic de Barcelona, Barcelona · Hospital Universitario de Cabueñes, Gijón · Hospital Universitario Virgen de la Victoria, Málaga · Clínica Universidad de navarra, Pamplona · Hospital Universitario De Salamanca, Salamanca
Registry updated 2026-11-03
NCT06527521
Prevalence of Amyloidosis in Trauma Patients
Research · Consorci Sanitari de l'Alt Penedès i Garraf
Consorci Sanitari Alt Penedes i Garraf-Hospital Sant Camil, Sant Pere de Ribes
Registry updated 2026-10-27
NCT06679946
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Trial Treatment · Phase 3 · Alnylam Pharmaceuticals
Barcelona · Bilbao · L'Hospitalet de Llobregat · Madrid · Málaga
Registry updated 2026-10-21
NCT07207811
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Trial Treatment · Phase 3 · Novo Nordisk A/S
Complejo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitari Germans Trias I Pujol (Hugtp), Badalona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Clinic de Barcelona (Hospital Clinic i Provincial), Barcelona · Hospital Universitario Vall d'Hebron, Barcelona · Hospital Universitario de Basurto, Bilbao · Hospital Universitario Reina Sofia, Córdoba · Hospital Universitario Donostia, Donostia / San Sebastian · Hospital Universitario Doctor Negrin, Las Palmas de Gran Canaria · Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario La Paz, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Hospital Universitario Virgen de la Victoria, Málaga · Hospital Son Llatzer (HSLL), Palma de Mallorca · Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela · Universidad de Sevilla - Hospital Universitario Virgen Macarena, Seville · Hospital Universitario Virgen del Rocio, Seville · Servicio Andaluz de Salud (SAS) - Hospital San Juan de la Cruz, Úbeda · Universitat de Valencia - Hospital Universitari i Politecnic La Fe de Valencia (Hospital La Fe Bulevar Sur), Valencia · Fundacion Investigacion Clinico de Valencia (FIHCUV) - Instituto de Investigacion Sanitaria (INCLIVA), Valencia · Hospital Clinico Universitario Lozano Blesa de Zaragoza, Zaragoza
Registry updated 2026-10-21
NCT07052903
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Trial Treatment · Phase 3 · Alnylam Pharmaceuticals
Area Sanitaria Da Coruna E Cee, A Coruna · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitario Basurto, Bilbao · Hospital Universitario Juan Ramon Jimenez, Huelva · Hospital Universitario de Jaén, Jaén · Bellvitge University Hospital, L'hospitalet De Llobregat · Hospital Universitari Arnau De Vilanova De La Gerencia Territorial De Lleida, Lleida · Hospital Universitario La Paz, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · University Clinical Hospital Virgen De La Arrixaca, Murcia · Hospital Son Llatzer, Palma · Clínica Universidad de navarra, Pamplona · Hospital Universitario De Salamanca, Salamanca · Fundacion Publica Galega Instituto De Investigacion Sanitaria De Santiago De Compostela, Santiago De Compostela · Hospital Universitario Y Politecnico La Fe, Valencia · Hospital Clinico Universitario de Valencia, Valencia · Complexo Hospitalario Universitario De Vigo, Vigo
Registry updated 2026-10-20
NCT04561518
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
Research · Alnylam Pharmaceuticals
Barcelona · Madrid · Palma
Registry updated 2026-10-13
NCT05040373
Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program
Research · Alnylam Pharmaceuticals
Madrid
Registry updated 2026-10-08
NCT07223203
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
Trial Treatment · Phase 3 · Alnylam Pharmaceuticals
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Juan Ramon Jimenez, Huelva · Bellvitge University Hospital, L'hospitalet De Llobregat · Hospital Clínico San Carlos, Madrid · Hospital Son Llatzer, Palma
Registry updated 2026-10-08
NCT07235462
A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting
Research · Bayer
Many Locations, Multiple Locations
Registry updated 2026-10-08
NCT06768489
A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Hospital Clinic de Barcelona, Barcelona · Hospital Universitario De Salamanca, Salamanca
Registry updated 2026-09-25
NCT06465810
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Research · AstraZeneca
Barcelona · Bilbao · Cataluna · Huelva · Islas Baleares · Las Palmas de Gran Canaria · Majadahonda · Salamanca
Registry updated 2026-09-23
NCT07654855
Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations
Research · AstraZeneca
Majadahonda
Registry updated 2026-09-14
NCT06355934
OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
Research · AstraZeneca
A Coruña · Barcelona · Bilbao · El Palmar · Huelva · Las Palmas de Gran Canaria · Madrid · Majadahonda · Palma de Mallorca · Salamanca · Valencia
Registry updated 2026-09-09
NCT06292780
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
Trial Treatment · Phase 1/2 · Regeneron Pharmaceuticals
Hospital Clinic de Barcelona, Barcelona · Hospital Universitario de Cabueñes, Gijón · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario De Móstoles, Móstoles · University Clinical Hospital Virgen De La Arrixaca, Murcia · University Hospital Son Espases, Palma · Clínica Universidad de navarra, Pamplona · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-08-18
NCT07116473
To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)
Trial Treatment · Phase 3 · Eidos Therapeutics, a BridgeBio company
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitario Juan Ramon Jimenez, Huelva · Bellvitge University Hospital, L'hospitalet De Llobregat · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Hospital Son Llatzer, Palma · Hospital Universitario De Salamanca, Salamanca
Registry updated 2026-08-11
NCT06563895
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Trial Treatment · Phase 3 · Eidos Therapeutics, a BridgeBio company
Area Sanitaria Da Coruna E Cee, A Coruna · Hospital Universitario Juan Ramon Jimenez, Huelva · Bellvitge University Hospital, L'hospitalet De Llobregat · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Hospital Son Llatzer, Palma · Hospital Universitario De Salamanca, Salamanca
Registry updated 2026-08-04
NCT07695701
Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
Trial Treatment · Phase 4 · Eidos Therapeutics, a BridgeBio company
Hospital Universitario Juan Ramon Jimenez, Huelva · Bellvitge University Hospital, L'hospitalet De Llobregat · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Hospital Son Llatzer, Palma · Complejo Asistencial Universitario de Salamanca, Salamanca
Registry updated 2026-07-29
NCT05667493
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
Trial Treatment · Phase 3 · Ionis Pharmaceuticals, Inc.
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Puerta de Hierro, Majadahonda · Hospital Clínico Universitario Virgen de la Arrixaca, Murcia · Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela
Registry updated 2026-04-17
NCT06205953
A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREKA)
Research · Fondazione IRCCS Policlinico San Matteo di Pavia
Instituto de Investigación Sanitaria de Navarra (IdiSNA) C. de Irunlarrea, 3, 31008 Pamplona, Navarra, Pamplona
Registry updated 2026-04-16
NCT06712030
Effect of Angiotensin Receptor/Neprilysin Inhibitors on Transthyretin Cardiac Amyloidosis and Heart Failure with Reduced Ejection Fraction
Trial Treatment · Phase 3 · Puerta de Hierro University Hospital
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Clinic de Barcelona, Barcelona · Hospital General Universitario de Ciudad Real, Ciudad Real · Hospital Universitario Donostia, Donostia · Bellvitge University Hospital, L'hospitalet De Llobregat · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Hospital Universitario De Salamanca, Salamanca · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · Hospital Clinico Universitario Lozano Blesa, Zaragoza
Registry updated 2024-12-02

All Amyloidosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error